Stegh Alexander H, Kesari Santosh, Mahoney John E, Jenq Harry T, Forloney Kristin L, Protopopov Alexei, Louis David N, Chin Lynda, DePinho Ronald A
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10703-8. doi: 10.1073/pnas.0712034105. Epub 2008 Jul 31.
Glioblastoma multiforme (GBM) is a highly aggressive brain cancer that is characterized by the paradoxical features of intense apoptosis resistance yet a marked propensity to undergo necrosis. Bcl2L12 (for Bcl2-Like12) is a nuclear and cytoplasmic oncoprotein that is universally overexpressed in primary GBM and functions to block postmitochondrial apoptosis signaling by neutralizing effector caspase-3 and caspase-7 maturation. This postmitochondrial block in apoptosis engenders the alternate cell fate of cellular necrosis, thus providing a molecular explanation for GBM's classical features. Whereas Bcl2L12-mediated neutralization of caspase-7 maturation involves physical interaction, the mechanism governing Bcl2L12-mediated inhibition of caspase-3 activity is not known. The nuclear localization of Bcl2L12 prompted expression profile studies of primary astrocytes engineered to overexpress Bcl2L12. The Bcl2L12 transcriptome revealed a striking induction of the small heat shock protein alpha-basic-crystallin (alphaB-crystallin/HspB5), a link reinforced by robust alphaB-crystallin expression in Bcl2L12-expressing orthotopic glioma and strong coexpression of alphaB-crystallin and Bcl2L12 proteins in human primary GBMs. On the functional level, enforced alphaB-crystallin or Bcl2L12 expression enhances orthotopic tumor growth. Conversely, RNAi-mediated knockdown of alphaB-crystallin in Bcl2L12-expressing astrocytes and glioma cell lines with high endogenous alphaB-crystallin showed enhanced apoptosis, yet decreased necrotic cell death with associated increased caspase-3 but not caspase-7 activation. Mirroring this specific effect on effector caspase-3 activation, alphaB-crystallin selectively binds pro-caspase-3 and its cleavage intermediates in vitro and in vivo. Thus, alphaB-crystallin is a Bcl2L12-induced oncoprotein that enables Bcl2L12 to block the activation of both effector caspases via distinct mechanisms, thereby contributing to GBM pathogenesis and its hallmark biological properties.
多形性胶质母细胞瘤(GBM)是一种极具侵袭性的脑癌,其特征是具有强烈的抗凋亡能力,但又有明显的坏死倾向,这两种特征相互矛盾。Bcl2L12(Bcl2样蛋白12)是一种在细胞核和细胞质中均有表达的癌蛋白,在原发性GBM中普遍过表达,其功能是通过中和效应半胱天冬酶-3和半胱天冬酶-7的成熟来阻断线粒体后凋亡信号传导。这种线粒体后凋亡阻断导致细胞坏死这一替代细胞命运,从而为GBM的经典特征提供了分子解释。虽然Bcl2L12介导的半胱天冬酶-7成熟的中和涉及物理相互作用,但Bcl2L12介导的半胱天冬酶-3活性抑制机制尚不清楚。Bcl2L12的核定位促使对经基因工程改造过表达Bcl2L12的原代星形胶质细胞进行表达谱研究。Bcl2L12转录组显示小热休克蛋白α-碱性晶状体蛋白(αB-晶状体蛋白/HspB5)有显著诱导,在表达Bcl2L12的原位胶质瘤中αB-晶状体蛋白的强烈表达以及在人类原发性GBM中αB-晶状体蛋白和Bcl2L12蛋白的强共表达加强了这种联系。在功能水平上,强制表达αB-晶状体蛋白或Bcl2L12可促进原位肿瘤生长。相反,在表达Bcl2L12的星形胶质细胞和内源性αB-晶状体蛋白含量高的胶质瘤细胞系中,通过RNA干扰介导的αB-晶状体蛋白敲低显示凋亡增加,但坏死性细胞死亡减少,同时半胱天冬酶-3激活增加,而半胱天冬酶-7激活未增加。与对效应半胱天冬酶-3激活的这种特异性作用一致,αB-晶状体蛋白在体外和体内均选择性结合前体半胱天冬酶-3及其切割中间体。因此,αB-晶状体蛋白是一种由Bcl2L12诱导的癌蛋白,它使Bcl2L12能够通过不同机制阻断两种效应半胱天冬酶的激活,从而促进GBM的发病机制及其标志性生物学特性。